Faculty Appointments
Director of the Vanderbilt-Ingram Cancer Center Professor of Medicine
Benjamin F. Byrd, Jr., Chair in Oncology
Education
M.D., University of Pennsylvania, Philadelphia, PennsylvaniaPh.D., Immunology, University of Pennsylvania, Philadelphia, PennsylvaniaA.B., Biology, University of Chicago, Chicago, Illinois
Office Address
2220 Pierce Avenue, room 698
Nashville, TN 37232
Nashville, TN 37232
Research Description
benhopark.com
Clinical Description
Breast cancer oncology
Research Keywords
Cancer biology, genetics, molecular biology
Clinical Research Keywords
Medical oncology
Publications
Karthikeyan S, Park BH. Circulating Tumor DNA as a Marker for Disease Relapse in Early-Stage Breast Cancer-Bad Blood. JAMA Oncol [print-electronic]. 2019 Aug 8/1/2019; PMID: 31369044, PII: 2740688, DOI: 10.1001/jamaoncol.2019.2047, ISSN: 2374-2445.
Zhang X, Wang Y, Chiang HC, Hsieh YP, Lu C, Park BH, Jatoi I, Jin VX, Hu Y, Li R. BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells. Breast Cancer Res. 2019 Apr 4/17/2019; 21(1): 51. PMID: 30995943, PMCID: PMC6472090, PII: 10.1186/s13058-019-1132-1, DOI: 10.1186/s13058-019-1132-1, ISSN: 1465-542X.
Button B, Croessmann S, Chu D, Rosen DM, Zabransky DJ, Dalton WB, Cravero K, Kyker-Snowman K, Waters I, Karthikeyan S, Christenson ES, Donaldson J, Hunter T, Dennison L, Ramin C, May B, Roden R, Petry D, Armstrong DK, Visvanathan K, Park BH. The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies. Breast Cancer Res. Treat [print-electronic]. 2019 Apr; 174(2): 401-12. PMID: 30560461, PMCID: PMC6447053, PII: 10.1007/s10549-018-05087-7, DOI: 10.1007/s10549-018-05087-7, ISSN: 1573-7217.
Connolly RM, Leal JP, Solnes L, Huang CY, Carpenter A, Gaffney K, Abramson V, Carey LA, Liu MC, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Krop IE, Winer EP, Camp M, Miller RS, Wolff AC, Cimino-Mathews A, Park BH, Wahl RL, Stearns V. TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. J. Clin. Oncol [print-electronic]. 2019 Mar 3/20/2019; 37(9): 714-22. PMID: 30721110, PMCID: PMC6424139, DOI: 10.1200/JCO.2018.78.7986, ISSN: 1527-7755.
Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, Elias AD, Baskin-Bey ES, Cardoso F. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res. Treat [print-electronic]. 2018 Sep 9/28/2018; PMID: 30267249, PII: 10.1007/s10549-018-4921-9, DOI: 10.1007/s10549-018-4921-9, ISSN: 1573-7217.
Zabransky DJ, Yankaskas CL, Cochran RL, Wong HY, Croessmann S, Chu D, Kavuri SM, Red Brewer M, Rosen DM, Dalton WB, Cimino-Mathews A, Cravero K, Button B, Kyker-Snowman K, Cidado J, Erlanger B, Parsons HA, Manto KM, Bose R, Lauring J, Arteaga CL, Konstantopoulos K, Park BH. HER2 missense mutations have distinct effects on oncogenic signaling and migration. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Nov 11/10/2015; 112(45): E6205-14. PMID: 26508629, PMCID: PMC4653184, PII: 1516853112, DOI: 10.1073/pnas.1516853112, ISSN: 1091-6490.
Young CD, Zimmerman LJ, Hoshino D, Formisano L, Hanker AB, Gatza ML, Morrison MM, Moore PD, Whitwell CA, Dave B, Stricker T, Bhola NE, Silva GO, Patel P, Brantley-Sieders DM, Levin M, Horiates M, Palma NA, Wang K, Stephens PJ, Perou CM, Weaver AM, O'Shaughnessy JA, Chang JC, Park BH, Liebler DC, Cook RS, Arteaga CL. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer. Mol. Cell Proteomics [print-electronic]. 2015 Jul; 14(7): 1959-76. PMID: 25953087, PMCID: PMC4587316, PII: M115.049783, DOI: 10.1074/mcp.M115.049783, ISSN: 1535-9484.
Zhang X, Wang Y, Chiang HC, Hsieh YP, Lu C, Park BH, Jatoi I, Jin VX, Hu Y, Li R. BRCA1 mutations attenuate super-enhancer function and chromatin looping in haploinsufficient human breast epithelial cells. Breast Cancer Res. 2019 Apr 4/17/2019; 21(1): 51. PMID: 30995943, PMCID: PMC6472090, PII: 10.1186/s13058-019-1132-1, DOI: 10.1186/s13058-019-1132-1, ISSN: 1465-542X.
Button B, Croessmann S, Chu D, Rosen DM, Zabransky DJ, Dalton WB, Cravero K, Kyker-Snowman K, Waters I, Karthikeyan S, Christenson ES, Donaldson J, Hunter T, Dennison L, Ramin C, May B, Roden R, Petry D, Armstrong DK, Visvanathan K, Park BH. The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies. Breast Cancer Res. Treat [print-electronic]. 2019 Apr; 174(2): 401-12. PMID: 30560461, PMCID: PMC6447053, PII: 10.1007/s10549-018-05087-7, DOI: 10.1007/s10549-018-05087-7, ISSN: 1573-7217.
Connolly RM, Leal JP, Solnes L, Huang CY, Carpenter A, Gaffney K, Abramson V, Carey LA, Liu MC, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Krop IE, Winer EP, Camp M, Miller RS, Wolff AC, Cimino-Mathews A, Park BH, Wahl RL, Stearns V. TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. J. Clin. Oncol [print-electronic]. 2019 Mar 3/20/2019; 37(9): 714-22. PMID: 30721110, PMCID: PMC6424139, DOI: 10.1200/JCO.2018.78.7986, ISSN: 1527-7755.
Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, Elias AD, Baskin-Bey ES, Cardoso F. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res. Treat [print-electronic]. 2018 Sep 9/28/2018; PMID: 30267249, PII: 10.1007/s10549-018-4921-9, DOI: 10.1007/s10549-018-4921-9, ISSN: 1573-7217.
Zabransky DJ, Yankaskas CL, Cochran RL, Wong HY, Croessmann S, Chu D, Kavuri SM, Red Brewer M, Rosen DM, Dalton WB, Cimino-Mathews A, Cravero K, Button B, Kyker-Snowman K, Cidado J, Erlanger B, Parsons HA, Manto KM, Bose R, Lauring J, Arteaga CL, Konstantopoulos K, Park BH. HER2 missense mutations have distinct effects on oncogenic signaling and migration. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2015 Nov 11/10/2015; 112(45): E6205-14. PMID: 26508629, PMCID: PMC4653184, PII: 1516853112, DOI: 10.1073/pnas.1516853112, ISSN: 1091-6490.
Young CD, Zimmerman LJ, Hoshino D, Formisano L, Hanker AB, Gatza ML, Morrison MM, Moore PD, Whitwell CA, Dave B, Stricker T, Bhola NE, Silva GO, Patel P, Brantley-Sieders DM, Levin M, Horiates M, Palma NA, Wang K, Stephens PJ, Perou CM, Weaver AM, O'Shaughnessy JA, Chang JC, Park BH, Liebler DC, Cook RS, Arteaga CL. Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer. Mol. Cell Proteomics [print-electronic]. 2015 Jul; 14(7): 1959-76. PMID: 25953087, PMCID: PMC4587316, PII: M115.049783, DOI: 10.1074/mcp.M115.049783, ISSN: 1535-9484.